 |
|
|
|
|
|
 |
 |
| |
|
Section I
Table S4. Additional T-ALL
samples with MLL gene rearrangements
| Case identifiera |
subtypeb |
translocationc |
Sampled |
% blastse |
| T-ALL#11 |
T-ALL, MLL |
t(11;15)(q23;q15) |
BM |
73 |
| T-ALL#12 |
T-ALL, MLL |
t(11;19) MLL-ENL |
PB |
92 |
| T-ALL#13 |
T-ALL, MLL |
t(11;19) MLL-ENL |
PB |
97 |
| T-ALL#14 |
T-ALL, MLL |
t(11;19) MLL-ENL |
PB |
98 |
| T-ALL-C20* |
T-ALL, MLL |
t(11;19) MLL-ENL |
BM |
98 |
aall samples were
bone marrow aspirates obtained at the time
of diagnosis of de novo AML
btranslocation as determined
by at least two tests: cytogenetics, FISH,
and/or RT-PCR
cadditional cytogenetic and molecular
information
dsample obtained where BM = bone
marrow; PB = peripheral blood
*this sample is part of the ALL dataset previously published
in Blood 1 . It is listed here to present information
regarding MLL-ENL translocation.
|
|
|
|
|
| |
|
|
